Blood And Marrow Transplant Handbook Comprehensive Guide For Patient Care 3Ed (Pb 2021) by MAZIARZ R T, SPRINGER

Description

SPRINGER Blood And Marrow Transplant Handbook Comprehensive Guide For Patient Care 3Ed (Pb 2021) by MAZIARZ R T

This updated and expanded edition developed by the Blood and Marrow Stem Cell Transplant team at Oregon Health & Science University Knight Cancer Institute features the latest medical management guidelines and standards of care for hematopoietic stem cell transplant and cellular therapy patients. _x000D__x000D_Spanning the timeline from the initial consultation throughout the transplant process, this handbook begins by providing a general overview of stem cell transplantation and goes on to outline disease-specific indications for stem cell transplantation. It then focuses on transplant complications and ongoing care, and finally explores cellular therapies for hematologic malignancies._x000D__x000D_Comprehensive and easy-to-use, Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care, Third Edition presents a multidisciplinary approach to information for physicians and advanced practice medical providers as well as residents, fellows, and other trainees who care for patients who undergo transplant and immune effector cell therapy._x000D_ _x000D_ Overview of Hematopoietic Stem Cell Transplantation & Cellular Therapy_x000D_ _x000D_ The Business of Cellular Therapy and Hematopoietic Stem Cell Transplantation_x000D_ _x000D_ Hematopoietic Stem Cell Sources and Donor Selection_x000D_ _x000D_ Pre-transplant Assessment for Hematopoietic Stem Cell Transplantation Recipients and Donors_x000D_ _x000D_ Social Work: Evaluation and Social Supports_x000D_ _x000D_ Conditioning Regimens_x000D_ _x000D_ Nutrition_x000D_ _x000D_ Physical and Occupational Therapy_x000D_ _x000D_ Adolescent and Young Adult Concerns_x000D_ _x000D_ Infection Prevention and Prophylaxis_x000D_ _x000D_ Graft-versus-Host Disease (GvHD) Prophylaxis _x000D_ _x000D_ Transfusion Medicine_x000D_ _x000D_ Anticoagulation and Antiplatelet Guidelines_x000D_ _x000D_ Engraftment_x000D_ _x000D_ Acute Myeloid Leukemia and Allogeneic Hematopoietic Stem Cell Transplant _x000D_ _x000D_ Acute Lymphoblastic Leukemia_x000D_ _x000D_ Hodgkin Lymphoma and non-Hodgkin Lymphoma_x000D_ _x000D_ Multiple Myeloma_x000D_ _x000D_ HSCT for Germ Cell Tumors_x000D_ _x000D_ Hematopoietic Stem Cell Transplant for Myelofibrosis_x000D_ _x000D_ Chronic Myeloid Leukemia_x000D_ _x000D_ Chronic Lymphocytic Leukemia_x000D_ _x000D_ Hematopoietic Stem Cell Transplant for Severe Aplastic Anemia_x000D_ _x000D_ Inherited Disorders_x000D_ _x000D_ Hematopoietic Cell Transplant and Cellular Therapies for Sickle Cell Disease_x000D_ _x000D_ Radiology Pearls for the Transplant Provider_x000D_ _x000D_ Acute Graft-Versus-Host Disease (GvHD)_x000D_ _x000D_ Chronic Graft-versus-Host Disease_x000D_ _x000D_ Immune Reconstitution_x000D_ _x000D_ Infectious Complications _x000D_ _x000D_ Oral Complications_x000D_ _x000D_ Gastrointestinal Complications_x000D_ _x000D_ Pulmonary Complications_x000D_ _x000D_ Cardiovascular Complications_x000D_ _x000D_ Kidney Disease in Hematopoietic Stem Cell Transplantation_x000D_ _x000D_ Neurological Complications_x000D_ _x000D_ Endocrine Complications following Hematopoietic Stem Cell Transplantation_x000D_ _x000D_ Thrombotic Microangiopathies_x000D_ _x000D_ Women's Health Care_x000D_ _x000D_ Men's Health for Bone Marrow Transplant Patients_x000D_ _x000D_ Psychiatric Complications_x000D_ _x000D_ Graft Failure_x000D_ _x000D_ Second Primary Malignancies _x000D_ _x000D_ Relapse after Hematopoietic Stem Cell Transplantation_x000D_ _x000D_ Safe Pain Management with Opioids in Post-Transplant Patients_x000D_ _x000D_ Complementary Medicine: Acupuncture_x000D_ _x000D_ Complementary Medicine_x000D_ _x000D_ Complementary Medicine: Cannabinoids and the Hematopoietic Stem Cell Transplant (HSCT) Recipient_x000D_ _x000D_ Management of Neurocognitive Effects and Fatigue During and After Stem Cell Transplant_x000D_ _x000D_ Palliative Care_x000D_ _x000D_ Long-Term Follow Up and Survivorship_x000D_ _x000D_ CAR T Cells for Hematologic Malignancies_x000D_ _x000D_ Natural Killer Cell Therapy in Allogeneic Stem Cell Transplant _x000D_ _x000D_ Mesenchymal stromal cells: Impact on hematopoietic cell transplantation_x000D_ _x000D_ T cell Therapeutics: Donor Lymphocyte Infusion, Cytotoxic T Lymphocyte Infusion and Other Non-CAR T cell Therapies_x000D_ _x000D_ Dendritic Cell Vaccines_x000D_ _x000D_ BiTEs, DARTs and Peri-Transplant Minimal Residual Disease_x000D_ _x000D_ CAR T Toxicity Management: Cytokine Release Syndrome and Neurotoxicity_x000D_ _x000D_ Molecular testing for post-transplant surveillance _x000D_ _x000D_ Management of Immune Compromised Transplant and Immune Effector Cell Treated Patients in the Setting of the COVID-19 Viral Pandemic: the OHSU Experience_x000D_ _x000D_ Appendix 1: The Vocabulary of Transplant_x000D_ _x000D_ Appendix 2: Procedure - Bone Marrow Aspirate and Biopsy _x000D_ _x000D_ Appendix 3: Procedure - Lumbar Puncture _x000D_ _x000D_ Appendix 4: Procedure - Ommaya reservoir tap_x000D_ _x000D_ Appendix 5: Procedure - Skin Biopsy _x000D_ _x000D_ Appendix 6: OHSU Food Safe Diet_x000D_ _x000D_ Appendix 7: OHSU Low Bacteria Diet_x000D_ _x000D_ Appendix 8: OHSU's Graft-versus-host disease diet_x000D_ _x000D_ Appendix 9: OHSU vaccine guidelines_x000D_ _x000D_ Appendix 10: OHSU Donor and stem cell source selection in allogeneic hematopoietic progenitor cell transplantation_x000D_